Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 381 clinical trials
  • 0 views
  • 16 Oct, 2022
  • 30 locations
En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer

Aim: To compare the surgical method of En Bloc resection to the conventional transurethral resection of non-muscle invasive bladder cancer (NMIBC) in terms of complete removal of tumour

  • 0 views
  • 03 Jul, 2022
  • 2 locations
OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer

This phase Ⅰb/Ⅱ study evaluates the safety and efficacy of OH2 for adjuvant therapy in non-muscle-invasive bladder cancer after first-line prophylactic intravesical instillation therapy.

  • 0 views
  • 04 Oct, 2022
  • 1 location
Low Energy Shock Wave Therapy and Non-Muscle Invasive Bladder Cancer

The investigators hypothesize that low energy shock wave therapy (LESW) might induce damage to the tumor tissues of non-muscle invasive bladder cancer (NMIBC), so they could be ablated and

  • 0 views
  • 27 Jan, 2021
  • 1 location
Omega-3 Polyunsaturated Fatty Acids and Non-Muscle Invasive Bladder Cancer

The investigators hypothesize that omega-3 polyunsaturated fatty acids (n-3 PUFAs) might have a role in prevention of the recurrence of non-muscle invasive bladder cancer (NMIBC). The

  • 0 views
  • 28 Jan, 2021
  • 1 location
Phase II Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

eRapa (encapsulated rapamycin) will be investigated for secondary prevention in patients with diagnosed non-muscle invasive bladder cancer (NMIBC) through a phase II double-blind randomized

  • 0 views
  • 11 Oct, 2022
  • 3 locations
A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer

Neoadjuvant accelerated methotrexate/vinblastine/adriamycin/cisplatin (AMVAC) in combination with nivolumab is under evaluation for the treatment of muscle invasive bladder cancer (MIBC

  • 0 views
  • 22 Apr, 2022
  • 1 location
EffectiveNess of a Multimodal preHAbilitation Program in Patients With Muscle iNvasive Bladder canCEr (ENHANCE)

Currently, the potential value of a multimodal prehabilitation program in muscle invasive bladder cancer has not been extensively studied. The investigators designed the ENHANCE study to assess

  • 0 views
  • 04 Oct, 2022
  • 1 location
A Phase I Trial of Cancer-targeting Micelles for Non-myoinvasive Bladder Cancer

This clinical trial is to determine the safety and effectiveness of an investigational bladder cancer drug named "PLZ4-coated paclitaxel-loaded nanoscale micelle (PPM)." PPM is tiny particles

  • 0 views
  • 27 Oct, 2022
  • 1 location
A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer

neoadjuvant GC chemotherapy alone in adult participants with previously untreated muscle-invasive bladder cancer (MIBC).

transurethral resection
bladder tumor
radical cystectomy
bladder cancer
invasive bladder cancer
  • 98 views
  • 09 Jul, 2022
  • 164 locations